[1] Liu Y, Chen S,Zühlke L, et al. Global birth prevalence of congenital heart defects 1970—2017:Updated systematic review andMeta-analysis of 260 studies[J]. Int J Epidemiol, 2019(48): 455-463. [2] Franklin RCG,Béland MJ, Colan SD, et al. Nomenclature for congenital and paediatric cardiac disease:The International Paediatric and Congenital Cardiac Code(IPCCC) and the Eleventh Iteration of the International Classification of Diseases(ICD-11)[J]. Cardiol Young, 2017, 27(10): 1872-1938. [3] Hu XJ, Ma XJ, Zhao QM, et al. Pulse oximetry and auscultation for congenital heart disease detection[J]. Pediatrics,2017, 140(4): e20171154. [4] Plana MN, Zamora J, Suresh G,et al. Pulse oximetry screening for critical congenital heart defects[J]. Cochrane Database Syst Rev,2018, 3(3): CD011912. [5] Abbas A, Ewer AK.New born pulse oximetry screening: A global perspective[J].Early Hum Dev,2021,162:105457. [6] Pei L, Kang Y, Zhao Y, et al. Prevalence and risk factors of congenital heart defects among live births:A population-based cross-sectional survey in Shaanxi province, Northwestern China[J]. BMC Pediatr,2017(17)(1):18. [7] Zhao QM, Liu F, Wu L, et al. Prevalence of congenital heart disease at live birth in China[J]. J Pediatr, 2019(204):53-58. [8] Liu Y, Chen S, Zühlke L, et al. Global birth prevalence of congenital heart defects 1970—2017: Updated systematic review and meta-analysis of 260 studies[J]. Int J Epidemiol,2019, 48(2):455-463. [9] Zhang X, Sun Y, Zhu J, et al. Epidemiology, prenatal diagnosis, and neonatal outcomes of congenital heart defects in eastern China: A hospital-based multicenter study[J]. BMC Pediatr, 2020, 20(1):416. [10] Xie D, Fang J, Liu Z, et al. Epidemiology and major subtypes of congenital heart defects in Hunan Province, China[J]. Medicine(Baltimore), 2018, 97(31): e11770. [11] GBD 2017 Congenital Heart Disease Collaborators.Global, regional, and national burden of congenital heart disease, 1990—2017: A systematic analysis for the global burden of disease study 2017[J].Lancet Child Adolesc Health, 2020,4(3):185-200. [12] Mustafa HJ, Cross SN, Jacobs KM, et al. Preterm birth of infants prenatally diagnosed with congenital heart disease, characteristics, associations, and outcomes[J]. Pediatr Cardiol, 2020, 41(5): 972-978. [13] Anderson D, Aragon DC, Gonçalves-Ferri WA, et al. Prevalence and outcomes of congenital heart disease in very low birth weight preterm infants: An observational study from the Brazilian neonatal network database[J]. Pediatr Crit Care Med, 2021(22):e99-e108. [14] Matthiesen NB, Østergaard JR, Hjortdal VE, et al. Congenital heart defects and the risk of spontaneous preterm birth[J]. J Pediatr, 2021(229):168-174. [15] Shah AK, Dhalla NS. Effectiveness of some vitamins in the prevention of cardiovascular disease: A narrative review[J].Front Physiol, 2021(12):729255. [16] Gildestad T, Bjørge T, Haaland ØA, et al. Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway, 1999—2013[J]. Br J Nutr, 2020, 124(3):316-329. [17] Steurer MA, Baer RJ, Chambers CD, et al. Mortality and major neonatal morbidity in preterm infants with serious congenital heart disease[J]. J Pediatr, 2021(239): 110-116. [18] Tomotaki H, Toyoshima K, Tomotaki S, et al. Clinical features of very-low-birthweight infants with congenital heart disease[J]. Pediatr Int, 2021, 63(7): 806-812. [19] Costello JM, Bradley SM. Low birth weight and congenital heart disease: Current status and future directions[J]. J Pediatr, 2021(238):9-10. [20] Han S, Wei CY, Hou ZL, et al. Prevalence of congenital heart disease amongst schoolchildren in southwest China[J]. Indian Pediatr, 2020, 57(2):138-141. [21] Liu H, Hu YJ, Zheng SQ, et al. Effect of perfusate oxygenation on inflammatory response in congenital heart disease children from low versus high altitude[J]. J Thorac Cardiovasc Surg, 2021, 161(6):2180-2190. |